“There’s No Magic Pill to Help Me, Right?”: Sex After Early Midlife Bilateral Salpingo-Oophorectomy
4 affiliations
- 1Department of Psychology, University of Toronto, 100 St. George Street, Toronto, ON M5S 3G3 Canada
- 2Department of Psychology, University of British Columbia, Vancouver, BC Canada
- 3Rotman Research Institute, Baycrest Health Sciences, Toronto, ON Canada
- 4Tema Genus and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
Abstract
Women with risk-reducing bilateral salpingo-oophorectomy (RRBSO) report poorer sexual health than women of a similar age with intact ovaries. Since women with RRBSO lose the ability to make endogenous 17-β-estradiol (E2), open questions include whether: (1) poorer sexual function is associated with E2 loss and (2) exogenous estradiol therapy (ETBSO) is related to amelioration of objective decrements and subjective experiences. We combined online questionnaires with qualitative interviews to explore the sexual function of women with pathogenic variants in the BRCA1/2 genes and RRBSO not taking ETBSO (RRBSO) and those taking ETBSO (RRBSO + ETBSO). We compared their quantitative responses to those of age-matched women with intact ovaries (AMC) and women in spontaneous menopause (SM). RRBSO had lower total sexual function scores than AMC and more sexually related distress than AMC than SM. In terms of lived experience with RRBSO + /–ETBSO, qualitative interviews mirrored the quantitative data with reports of pain, loss of sexual desire, and dryness, in addition to concerns about identity, relational challenges, and lacking crucial information regarding sexual response after RRBSO. The combination of the objective and subjective reports details worse sexual function and experience of younger women with RRBSO regardless of ETBSO. Since ETBSO does not appear to ameliorate all aspects of sexual function and distress for many women with RRBSO, it is critical to consider other interventions including fully informed consent prior to RRBSO.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s10508-026-03548-5.
Related
- Persistently elevated estradiol after bilateral salpingo-oophorectomy in recurrent low-grade endometrial stromal sarcoma: a case report
- Projected Benefit of Bilateral Salpingo-Oophorectomy by Age in BRCA Carriers
- Cardiovascular risk factors at 24 months after risk-reducing salpingo-oophorectomy: a prospective controlled study from WHAM
- Vaginal natural orifice transluminal endoscopic surgery versus laparoscopy for salpingo-oophorectomy and adnexectomy: A systematic review and meta-analysis
- Protocol for bilateral oophorectomy in mice: a reliable and cost-effective model for promoting an obesogenic state.
BibTeX
@article{amarakoon2026theres,
title = {{“There’s No Magic Pill to Help Me, Right?”: Sex After Early Midlife Bilateral Salpingo-Oophorectomy}},
author = {Anuki Amarakoon and Jana Galley and Mateja Perović and Laurice Karkaby and Michelle Galper and Gillian Einstein},
journal = {Archives of Sexual Behavior},
year = {2026},
month = oct,
doi = {10.1007/s10508-026-03548-5},
url = {https://doi.org/10.1007/s10508-026-03548-5},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - “There’s No Magic Pill to Help Me, Right?”: Sex After Early Midlife Bilateral Salpingo-Oophorectomy
AU - Anuki Amarakoon
AU - Jana Galley
AU - Mateja Perović
AU - Laurice Karkaby
AU - Michelle Galper
AU - Gillian Einstein
PY - 2026
DA - 2026/10/15
JO - Archives of Sexual Behavior
DO - 10.1007/s10508-026-03548-5
UR - https://doi.org/10.1007/s10508-026-03548-5
AB - Women with risk-reducing bilateral salpingo-oophorectomy (RRBSO) report poorer sexual health than women of a similar age with intact ovaries. Since women with RRBSO lose the ability to make endogenous 17-β-estradiol (E2), open questions include whether: (1) poorer sexual function is associated with E2 loss and (2) exogenous estradiol therapy (ETBSO) is related to amelioration of objective decrements and subjective experiences. We combined online questionnaires with qualitative interviews to explore the sexual function of women with pathogenic variants in the BRCA1/2 genes and RRBSO not taking ETBSO (RRBSO) and those taking ETBSO (RRBSO + ETBSO). We compared their quantitative responses to those of age-matched women with intact ovaries (AMC) and women in spontaneous menopause (SM). RRBSO had lower total sexual function scores than AMC and more sexually related distress than AMC than SM. In terms of lived experience with RRBSO + /–ETBSO, qualitative interviews mirrored the quantitative data with reports of pain, loss of sexual desire, and dryness, in addition to concerns about identity, relational challenges, and lacking crucial information regarding sexual response after RRBSO. The combination of the objective and subjective reports details worse sexual function and experience of younger women with RRBSO regardless of ETBSO. Since ETBSO does not appear to ameliorate all aspects of sexual function and distress for many women with RRBSO, it is critical to consider other interventions including fully informed consent prior to RRBSO. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s10508-026-03548-5.
SN - 0004-0002
SN - 1573-2800
ER -